Literature DB >> 6317892

Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2.

R J Eisenberg, D Long, R Hogue-Angeletti, G H Cohen.   

Abstract

Glycoprotein D (gD) of herpes simplex virus is a structural component of the virion envelope which stimulates production of high titers of herpes simplex virus type-common neutralizing antibody. We carried out automated N-terminal amino acid sequencing studies on radiolabeled preparations of gD-1 (gD of herpes simplex virus type 1) and gD-2 (gD of herpes simplex virus type 2). Although some differences were noted, particularly in the methionine and alanine profiles for gD-1 and gD-2, the amino acid sequence of a number of the first 30 residues of the amino terminus of gD-1 and gD-2 appears to be quite similar. For both proteins, the first residue is a lysine. When we compared our sequence data for gD-1 with those predicted by nucleic acid sequencing, the two sequences could be aligned (with one exception) starting at residue 26 (lysine) of the predicted sequence. Thus, the first 25 amino acids of the predicted sequence are absent from the polypeptides isolated from infected cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317892      PMCID: PMC255451     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

3.  Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.

Authors:  W T Ruyechan; L S Morse; D M Knipe; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Application of sequenator analyses to the study of proteins.

Authors:  M A Hermodson; L H Ericsson; K Titani; H Neurath; K A Walsh
Journal:  Biochemistry       Date:  1972-11-21       Impact factor: 3.162

Review 6.  Immunochemistry of herpes simplex virus glycoproteins.

Authors:  B Norrild
Journal:  Curr Top Microbiol Immunol       Date:  1980       Impact factor: 4.291

Review 7.  Intertypic recombinants of herpes simplex viruses.

Authors:  I W Halliburton
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

8.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03

9.  Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1.

Authors:  G H Cohen; D Long; R J Eisenberg
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.

Authors:  G H Cohen; M Katze; C Hydrean-Stern; R J Eisenberg
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

View more
  21 in total

1.  Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein.

Authors:  D L Sodora; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  cis Requirement for N-specific protein sequence in bovine coronavirus defective interfering RNA replication.

Authors:  R Y Chang; D A Brian
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Computer predictions of antigenic domains in herpes simplex virus types 1 and 2 glycoprotein D as compared with experimentally proven domains.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

4.  Localization of epitopes of herpes simplex virus type 1 glycoprotein D.

Authors:  R J Eisenberg; D Long; M Ponce de Leon; J T Matthews; P G Spear; M G Gibson; L A Lasky; P Berman; E Golub; G H Cohen
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  An amino-terminal deletion mutation of pseudorabies virus glycoprotein gIII affects protein localization and RNA accumulation.

Authors:  L W Enquist; C L Keeler; A K Robbins; J P Ryan; M E Whealy
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro.

Authors:  W J Weijer; J W Drijfhout; H J Geerligs; W Bloemhoff; M Feijlbrief; C A Bos; P Hoogerhout; K E Kerling; T Popken-Boer; K Slopsema
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

7.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

8.  High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.

Authors:  W P Sisk; J D Bradley; R J Leipold; A M Stoltzfus; M Ponce de Leon; M Hilf; C Peng; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.

Authors:  D L Sodora; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D.

Authors:  A V Nicola; S H Willis; N N Naidoo; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.